262 related articles for article (PubMed ID: 24349473)
1. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
Parry M; Rose-Zerilli MJ; Gibson J; Ennis S; Walewska R; Forster J; Parker H; Davis Z; Gardiner A; Collins A; Oscier DG; Strefford JC
PLoS One; 2013; 8(12):e83244. PubMed ID: 24349473
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
[TBL] [Abstract][Full Text] [Related]
3. Splenic marginal zone lymphoma.
Piris MA; Onaindía A; Mollejo M
Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
[TBL] [Abstract][Full Text] [Related]
4. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G
J Exp Med; 2012 Aug; 209(9):1537-51. PubMed ID: 22891273
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
[TBL] [Abstract][Full Text] [Related]
6. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
7. The genetics of nodal marginal zone lymphoma.
Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D
Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277
[TBL] [Abstract][Full Text] [Related]
8. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
[TBL] [Abstract][Full Text] [Related]
9. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
10. Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
Parry M; Rose-Zerilli MJ; Ljungström V; Gibson J; Wang J; Walewska R; Parker H; Parker A; Davis Z; Gardiner A; McIver-Brown N; Kalpadakis C; Xochelli A; Anagnostopoulos A; Fazi C; de Castro DG; Dearden C; Pratt G; Rosenquist R; Ashton-Key M; Forconi F; Collins A; Ghia P; Matutes E; Pangalis G; Stamatopoulos K; Oscier D; Strefford JC
Clin Cancer Res; 2015 Sep; 21(18):4174-4183. PubMed ID: 25779943
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
Spina V; Rossi D
Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA losses in the frequently deleted region of 7q in SMZL.
Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
[No Abstract] [Full Text] [Related]
13. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.
Jaramillo Oquendo C; Parker H; Oscier D; Ennis S; Gibson J; Strefford JC
Sci Rep; 2019 Jul; 9(1):10444. PubMed ID: 31320741
[TBL] [Abstract][Full Text] [Related]
15. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
Kiel MJ; Velusamy T; Betz BL; Zhao L; Weigelin HG; Chiang MY; Huebner-Chan DR; Bailey NG; Yang DT; Bhagat G; Miranda RN; Bahler DW; Medeiros LJ; Lim MS; Elenitoba-Johnson KS
J Exp Med; 2012 Aug; 209(9):1553-65. PubMed ID: 22891276
[TBL] [Abstract][Full Text] [Related]
17. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
[TBL] [Abstract][Full Text] [Related]
18. Splenic marginal zone lymphoma: from genetics to management.
Arcaini L; Rossi D; Paulli M
Blood; 2016 Apr; 127(17):2072-81. PubMed ID: 26989207
[TBL] [Abstract][Full Text] [Related]
19. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
20. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]